154 related articles for article (PubMed ID: 15981554)
1. Two-stent techniques for the treatment of coronary bifurcations with drug-eluting stents.
Iakovou I; Colombo A
Hellenic J Cardiol; 2005; 46(3):188-98. PubMed ID: 15981554
[No Abstract] [Full Text] [Related]
2. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
Togni M; Räber L; Cocchia R; Wenaweser P; Cook S; Windecker S; Meier B; Hess OM
Int J Cardiol; 2007 Aug; 120(2):212-20. PubMed ID: 17234280
[TBL] [Abstract][Full Text] [Related]
3. Dual drug release from stents-will we be happy with thing one and thing two?
Hehrlein C
Catheter Cardiovasc Interv; 2007 Nov; 70(6):880. PubMed ID: 18022914
[No Abstract] [Full Text] [Related]
4. Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model.
Berg R; Aragon J; Royter V; Shanley JF; Cogert G; Vermani R; Kar S; Eigler N; Litvack F
Catheter Cardiovasc Interv; 2007 Nov; 70(6):871-9. PubMed ID: 17932889
[TBL] [Abstract][Full Text] [Related]
5. [Paclitaxel-eluting stents in treatment of stenoses and chronic occlusions of coronary arteries].
Maslov LN; Krylov AL
Angiol Sosud Khir; 2007; 13(3):53-60. PubMed ID: 18382394
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting stents for the treatment of in-stent restenosis--'real world' double centre experience in consecutive patients.
Anderson RA; Fath-Ordoubadi F; Younas S; Bainbridge A; Swallow RA; Dawkins KD; Curzen NP
Int J Cardiovasc Intervent; 2005; 7(4):188-92. PubMed ID: 16373265
[TBL] [Abstract][Full Text] [Related]
7. Registry data evaluating the effectiveness of drug-eluting stents for the treatment of symptomatic in-stent restenosis.
Worthley MI; Anderson TJ; Traboulsi M; Charbonneau F; Curtis MJ; Hansen JL; Knudtson ML; Spence FP; Goodhart DM
Heart Lung Circ; 2006 Oct; 15(5):300-5. PubMed ID: 16877042
[TBL] [Abstract][Full Text] [Related]
8. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis.
Eisenberg MJ; Konnyu KJ
Am J Cardiol; 2006 Aug; 98(3):375-82. PubMed ID: 16860027
[TBL] [Abstract][Full Text] [Related]
9. Application of paclitaxel-eluting metal stents in renal artery of pig model.
Voudoukis T; Liatsikos EN; Kagadis GC; Christeas N; Flaris N; Katsanos K; Costantinides C; Perimenis P; Scopa CD; Filos KS; Nikiforidis GC; Alexopoulos D; Siablis D
J Endourol; 2007 Dec; 21(12):1571-6. PubMed ID: 18044994
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
Liuzzo JP; Ambrose JA; Coppola JT
J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242
[TBL] [Abstract][Full Text] [Related]
11. A serial ultrasound assessment of neoaneurysm following paclitaxel-eluting stent implantation.
Park CS; Kim PJ; Park HJ; Jang SW; Jung HO; Kim HY; Baek SH; Seung KB; Choi KB; Lee DH
Int J Cardiol; 2007 Dec; 123(1):e21-2. PubMed ID: 17942175
[TBL] [Abstract][Full Text] [Related]
12. Integrity of stent polymer layer after drug-eluting stent implantation: in vivo comparison of sirolimus-, paclitaxel-, zotarolimus- and everolimus-eluting stents.
Watanabe T; Fujita M; Awata M; Iida O; Okamoto S; Ishihara T; Uematsu M
Cardiovasc Interv Ther; 2014 Jan; 29(1):4-10. PubMed ID: 23818255
[TBL] [Abstract][Full Text] [Related]
13. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation.
Gao RL; Xu B; Chen JL; Yang YJ; Qiao SB; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J
Am Heart J; 2008 Mar; 155(3):553-61. PubMed ID: 18294496
[TBL] [Abstract][Full Text] [Related]
14. Drug eluting stents for everyone and everything?
Laham RJ
Catheter Cardiovasc Interv; 2005 Dec; 66(4):512-3. PubMed ID: 16270362
[No Abstract] [Full Text] [Related]
15. Restenosis treatment in the drug-eluting stent era.
Presbitero P; Boccuzzi G
Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
[TBL] [Abstract][Full Text] [Related]
16. Impact of sirolimus-eluting and Paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery.
Stankovic G; Cosgrave J; Chieffo A; Iakovou I; Sangiorgi G; Montorfano M; Airoldi F; Carlino M; Michev I; Finci L; Colombo A
Am J Cardiol; 2006 Aug; 98(3):362-6. PubMed ID: 16860024
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus.
Kuchulakanti PK; Chu WW; Torguson R; Clavijo L; Wolfram R; Mishra S; Xue Z; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2006 Jul; 98(2):187-92. PubMed ID: 16828590
[TBL] [Abstract][Full Text] [Related]
18. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
[TBL] [Abstract][Full Text] [Related]
19. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
Büllesfeld L; Gerckens U; Müller R; Grube E
Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
[TBL] [Abstract][Full Text] [Related]
20. Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary artery.
Martin JL; Ellis SG; Colombo A; Grube E; Maloney T; Friedman MI; Baim DS; Dawkins K; Caputo R; Stone GW
Am J Cardiol; 2009 Jan; 103(1):11-6. PubMed ID: 19101222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
